Cytokinetics (CYTK) Assets Average (2016 - 2025)
Historic Assets Average for Cytokinetics (CYTK) over the last 15 years, with Q3 2024 value amounting to $1.5 billion.
- Cytokinetics' Assets Average rose 9466.11% to $1.5 billion in Q3 2024 from the same period last year, while for Sep 2024 it was $1.5 billion, marking a year-over-year increase of 9466.11%. This contributed to the annual value of $919.5 million for FY2023, which is 91.61% down from last year.
- Per Cytokinetics' latest filing, its Assets Average stood at $1.5 billion for Q3 2024, which was up 9466.11% from $1.2 billion recorded in Q2 2024.
- Over the past 5 years, Cytokinetics' Assets Average peaked at $1.5 billion during Q3 2024, and registered a low of $244.5 million during Q2 2020.
- For the 5-year period, Cytokinetics' Assets Average averaged around $760.8 million, with its median value being $814.0 million (2022).
- Per our database at Business Quant, Cytokinetics' Assets Average soared by 13337.1% in 2021 and then crashed by 2514.93% in 2023.
- Over the past 5 years, Cytokinetics' Assets Average (Quarter) stood at $504.0 million in 2020, then surged by 65.58% to $834.4 million in 2021, then rose by 25.28% to $1.0 billion in 2022, then dropped by 25.15% to $782.5 million in 2023, then soared by 89.14% to $1.5 billion in 2024.
- Its Assets Average was $1.5 billion in Q3 2024, compared to $1.2 billion in Q2 2024 and $816.2 million in Q1 2024.